FDA Approves Epidiolex For TSC, Atogepant Reduces Monthly Migraine Days, Lancet Publishes Updated Dementia Risk Factors
Fenfluramine FDA Approved for Dravet Syndrome, Insulin Shows No Impact in Alzheimer Disease, MS Patients Develop More Severe COVID-19 Conditions